Bremer Trust National Association’s AstraZeneca AZN Stock Holding History

Bremer Trust National Association’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$273K	Sell	3,596 -98	-3%	-$7.65K	0.06%	216
2018 Q3	$292K	Sell	3,694 -338	-8%	-$25.6K	0.07%	211
2018 Q2	$283K	Buy	4,032 +115	+3%	+$8.27K	0.08%	208
2018 Q1	$274K	Sell	3,917 -154	-4%	-$10.7K	0.08%	193
2017 Q4	$283K	Buy	+4,071	New	+$275K	0.08%	201
2015 Q1	–	Sell	-4,473	Closed	-$315K	–	230
2014 Q4	$315K	Sell	4,473 -407	-8%	-$29.1K	0.1%	168
2014 Q3	$349K	Sell	4,880 -428	-8%	-$31.3K	0.12%	154
2014 Q2	$394K	Sell	5,308 -4,636	-47%	-$335K	0.14%	143
2014 Q1	$645K	Sell	9,944 -1,609	-14%	-$104K	0.24%	102
2013 Q4	$686K	Buy	11,553 +123	+1%	+$6.68K	0.26%	93
2013 Q3	$593K	Sell	11,430 -118	-1%	-$5.93K	0.25%	97
2013 Q2	$546K	Buy	+11,548	New	+$588K	0.25%	94

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bremer Trust National Association's AZN Position: Q4 2018 in Review

Bremer Trust National Association reduced its AstraZeneca (AZN) stake by 2.7% in Q4 2018, selling an estimated $7.65K and leaving 3,596 shares worth $273K. The position accounts for 0.06% of the portfolio, ranked #216.

Bremer Trust National Association first reported a position in AZN in Q2 2013 and has held it in 12 quarters since. The position peaked at $686K in Q4 2013. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Bremer Trust National Association held 3,596 shares of AstraZeneca worth $273K as of Q4 2018.
Bremer Trust National Association sold 98 AstraZeneca shares in Q4 2018, an estimated $7.65K.
AstraZeneca made up 0.06% of Bremer Trust National Association's portfolio in Q4 2018, its #216 holding.
Bremer Trust National Association first reported a position in AstraZeneca in Q2 2013 and has held it in 12 quarters since.
Bremer Trust National Association's AstraZeneca position peaked at $686K in Q4 2013.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.